Pursuant to the authority of FAR 6.302-1, The Department of Health and Human Services (DHHS), Program Support Center (PSC), Acquisition Management Services (AMS), on behalf of the the Joint Program Executive Office for Chemical Biological Defense (JPEO-CBD) intends negotiate on a sole source basis an order with TUFTS University of Medicine.
The purpose of this sole-source is to perform an independent assessment and validation of the data gathering and analytics data that supports the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Cost Model Tool output.
Independent assessment of and validation the PHEMCE tool supporting data is needed. The assessment consists of a review the PHEMCE cost variables to build a concesus on metric definitions, cost data sources, data accessibility and utility that has already been completed by the interagency. Tufts University will hold in-person and teleconference meetings with the core team and the interagency to discuss cost model variables; metric definitions; cost data sources ease of data access; and assess a variety of analytics and their perceived value. . Tufts Univeristy will then prepare, facilitate and manage a process to validate the requirements of the cost tool. They will compile and analyze all of the program data collected and prepare custom reports to review and refine with the core team. As part of this process, Tufts University will apply and review statistical analyses, economic estimation practices and inflation factors used to support the development of the custom reports and output.
The Government's technical experts performed market research between April and May 2015 searching the website for universities that specialized in pharmaceutical economic development. Two universities were indentified; Tufts University of School of Medicine and Duke University Health Affairs. Although Duke University has the capability to perform this requirement, they lack the experience working with Public Health Emergency Medical Countermeaures Enterprise (PMEMCE) Cost Model Tool and the regulatory challenges of the FDA. An award to Duke would result in a learning curb that would be costly to the government in time and funding. Based on this market research, the Government's technical experts concluded only Tufts University School of Medicine can fulfill this requirement.
This notice of intent to award is not a request for competitive quotations. Interested concerns capable of providing the same or similar products or services as described in this notice may submit a capability statement outlining their capabilities. No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on
responses to this notice is solely within the discretion of the Government.
Bid Protests Not Available
G